Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galvin

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
Bioorganic & Medicinal Chemistry Letters|January 26, 2016
Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERGShih-Chung Huang, Sharmila Adhikari, Roushan Afroze, et al.
Medical Physics|October 1, 2010
Stereotactic body radiation therapy: the report of AAPM Task Group 101Stanley H Benedict, Kamil M Yenice, David Followill, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseMark G Manfredi, Jeffrey A Ecsedy, Kristan A Meetze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerJimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitorsAlexandra E Gould, Ruth Adams, Sharmila Adhikari, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
Bioorganic & Medicinal Chemistry Letters|January 26, 2016
Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERGShih-Chung Huang, Sharmila Adhikari, Roushan Afroze, et al.
Medical Physics|October 1, 2010
Stereotactic body radiation therapy: the report of AAPM Task Group 101Stanley H Benedict, Kamil M Yenice, David Followill, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseMark G Manfredi, Jeffrey A Ecsedy, Kristan A Meetze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerJimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitorsAlexandra E Gould, Ruth Adams, Sharmila Adhikari, et al.
Pageof 25